HYMPAVZI FDA approval date

The FDA approved HYMPAVZI on 11 Oct 2024.

FDA approval date
11 Oct 2024

Drug identity has not yet been verified against registry records

Also recorded as MARSTACIMAB-HNCQ

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2024-10-11DayHYMPAVZIFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA761369", "applicant_as_listed_by_fda": "PFIZER INC", "brand_names": ["HYMPAVZI"], "active_ingredients": ["MARSTACIMAB-HNCQ"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20241011", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026